FIELD: purification of botulinum toxin.
SUBSTANCE: invention relates to a method for purifying botulinum toxin, comprising (a) acid precipitation or ultrafiltration of a culture solution containing botulinum toxin type A; (b) purifying the pre-treated botulinum toxin by cation exchange chromatography using an SP column; (c) purification of botulinum toxin by hydrophobic chromatography using a phenyl column; and (d) purifying the botulinum toxin by anion exchange chromatography using a Q column.
EFFECT: method allows the botulinum toxin to be purified to a high degree of purity.
11 cl, 7 dwg, 9 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PURIFYING OF BOTULINUM TOXIN | 2020 |
|
RU2805226C2 |
METHOD OF PRODUCING BOTULINUM TOXIN | 2016 |
|
RU2707255C1 |
METHOD FOR BOTULINUM TOXIN PRODUCTION | 2014 |
|
RU2627159C2 |
METHOD OF OBTAINING BOTULINUM NEUROTOXIN (VERSIONS) | 2010 |
|
RU2561459C2 |
METHOD FOR PURIFYING DIGLYCOSYLATED INTERFERON-BETA PROTEIN | 2020 |
|
RU2795430C1 |
METHOD OF PURIFICATION OF PROTEINS | 2011 |
|
RU2610667C2 |
METHOD OF PURIFYING COAGULATION FACTOR VIII | 2009 |
|
RU2698392C2 |
METHOD FOR PURIFICATION OF BLOOD-COAGULATION FACTOR VIII | 2009 |
|
RU2567811C2 |
METHOD OF PURIFYING VITAMIN K-DEPENDENT PROTEINS, SUCH AS COAGULATION FACTOR VII | 2011 |
|
RU2731720C2 |
METHOD FOR PURIFYING VITAMIN K DEPENDENT PROTEINS SUCH AS COAGULATION FACTOR IX | 2011 |
|
RU2590726C2 |
Authors
Dates
2023-05-02—Published
2020-04-14—Filed